<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367644/" ref="ordinalpos=2294&amp;ncbi_uid=7321519&amp;link_uid=PMC4367644" image-link="/pmc/articles/PMC4367644/figure/f1/" class="imagepopup">Figure 1.  From: Inhibition of insulin-like growth factor receptor: end of a targeted therapy?. </a></div><br /><div class="p4l_captionBody">IGF-1R Signaling Pathway. IGF-1 is regulated by binding to insulin growth factor binding protein (IGFBP). Free IGF-1 can bind to IGF-1R, and activate downstream signaling through the insulin receptor substrate (IRS) to promote cell growth and proliferation (Ras/Raf/MEK pathway) and cell survival and cell cycle progression (PI3K/AKT/mTOR pathway)</div></div>